Approval · Notice of Compliance 36630 · 2025
JERAYGO: Notice of Compliance 36630
Issued December 23, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36630
- Date
- December 23, 2025
- Company
- Idorsia Pharmaceuticals LtdAllschwil, Basel-Landschaft, Switzerland
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
Medicinal ingredients
- APROCITENTAN 25 MG per TAB
- APROCITENTAN 12.5 MG per TAB